{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:50:08Z","timestamp":1791237008303,"version":"4.1.0"},"reference-count":84,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.2217\/fmb.12.56","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T11:11:54Z","timestamp":1343128314000},"page":"823-837","source":"Crossref","is-referenced-by-count":251,"title":["Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action"],"prefix":"10.1080","volume":"7","author":[{"given":"Katherine A","family":"Sacksteder","sequence":"first","affiliation":[{"name":"Sequella, Inc., Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Protopopova","sequence":"additional","affiliation":[{"name":"Sequella, Inc., Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton E","family":"Barry","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Section, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Andries","sequence":"additional","affiliation":[{"name":"Antimicrobial Research, Janssen Infectious Diseases, Beerse, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Nacy","sequence":"additional","affiliation":[{"name":"Sequella, Inc., Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-234"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.9.1009"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.5.1151"},{"issue":"4","key":"e_1_3_2_3_4_1","first-page":"320","volume":"10","author":"Castelnuovo B","year":"2010","unstructured":"Castelnuovo B . A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in sub Saharan Africa. Afr. Health Sci.10(4) , 320\u2013324 (2010).","journal-title":"Afr. Health Sci."},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37132011000200013"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406163302402"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.2.387"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3506(03)00035-0"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301702"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70041-6"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir858"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60410-2"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00168008"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-007-0039-7"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/518665"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020436"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538170-000000000-00000"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986708785132906"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0054-4"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200305q"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.11.46"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01204-07"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808427"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05708-11"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.794"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.05962.x"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00195210"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00009509"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.04.007"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/648675"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200806-892OC"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/647939"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1285"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02111491"},{"key":"e_1_3_2_3_35_1","first-page":"115","volume":"108","author":"Paramasivan CN","year":"1998","unstructured":"Paramasivan CN , KubendiranG, HerbertD. Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis. Indian J. Med. Res.108 , 115\u2013119 (1998).","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1086\/589515"},{"issue":"9","key":"e_1_3_2_3_37_1","first-page":"736","volume":"2","author":"Dhillon J","year":"1998","unstructured":"Dhillon J , AllenBW, HuYM, CoatesAR, MitchisonDA. Metronidazole has no antibacterial effect in Cornell model murine tuberculosis. Int. J. Tuberc. Lung Dis.2(9) , 736\u2013742 (1998).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1022-1025.2002"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0616"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01354-09"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm950956y"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1189"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06330.x"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01179-10"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1086\/655471"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/cc020071p"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1966.tb45527.x"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1966.tb45528.x"},{"issue":"11","key":"e_1_3_2_3_49_1","first-page":"1360","article-title":"Pharmacokinetics of ethambutol in children and adults with tuberculosis.","volume":"8","author":"Zhu M","year":"2004","unstructured":"Zhu M , BurmanWJ, StarkeJR et al. Pharmacokinetics of ethambutol in children and adults with tuberculosis. Int. J. Tuberc. Lung Dis. 8(11) , 1360\u20131367 (2004).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.182.7.1802-1811.2000"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.07.015"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050948"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.10.135"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki319"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2004.11.036"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4550-4555.2004"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2011.01242.x"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.01.046"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.07.126"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705984"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.134.3.713"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.01.065"},{"issue":"12","key":"e_1_3_2_3_63_1","first-page":"1318","volume":"10","author":"Donald PR","year":"2006","unstructured":"Donald PR , MaherD, MaritzJS, QaziS. Ethambutol dosage for the treatment of children: literature review and recommendations. Int. J. Tuberc. Lung Dis.10(12) , 1318\u20131330 (2006).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406796200"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.087817"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00162-09"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.9.1493"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl227"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0077OC"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.5.615"},{"issue":"7","key":"e_1_3_2_3_71_1","first-page":"862","volume":"8","author":"Langdon G","year":"2004","unstructured":"Langdon G , WilkinsJJ, SmithPJ, McIlleronH. Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis.8(7) , 862\u2013867 (2004).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr589"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030479"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01601-09"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.091"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01326-06"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706650"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1677"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq120"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11919"},{"key":"e_1_3_2_4_2_1","unstructured":"WHO. Global Tuberculosis Control 2011. (2011). www.who.int\/tb\/publications\/global_report\/en"},{"key":"e_1_3_2_4_3_1","unstructured":"Linezolid to Treat Extensively-Drug Resistant Tuberculosis. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00727844"},{"key":"e_1_3_2_4_4_1","unstructured":"Metronidazole for Pulmonary Tuberculosis (South Korea). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00425113"},{"key":"e_1_3_2_4_5_1","unstructured":"US Department of Health and Human Services US FDA Center for Drug Evaluation and Research (CDER). New Guidance for Industry: Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination. (December 2010). www.fda.gov\/ForConsumers\/ByAudience\/ForPatientAdvocates\/ucm237264.htm"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.12.56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:39:51Z","timestamp":1719110391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.12.56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.2217\/fmb.12.56"],"URL":"https:\/\/doi.org\/10.2217\/fmb.12.56","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}